|
|
|
Feed Submission If you'd like OHCNetwork Health News to link to your health news or blog from this category (Medications and Drugs), please submit your RSS or XML feed to OHCNetwork Health News. Contact information is available here. |
Health News >> Medications and Drugs
Categories
|
Pharmaceuticals ... |
Statins ... |
Medications and Drugs News
MedicineNet Medications General
Title: Gardasil (HPV Vaccine)
Category: Medications
Created: 8/21/2008
Last Editorial Review: 8/21/2008
Category: Medications
Created: 8/21/2008
Last Editorial Review: 8/21/2008
MedicineNet Medications General
Title: prednisolone, Pediapred Oral Liquid, Medrol
Category: Medications
Created: 12/31/1997
Last Editorial Review: 8/7/2008
Category: Medications
Created: 12/31/1997
Last Editorial Review: 8/7/2008
MedicineNet Medications General
Title: nabumetone, Relafen
Category: Medications
Created: 12/31/1997
Last Editorial Review: 8/7/2008
Category: Medications
Created: 12/31/1997
Last Editorial Review: 8/7/2008
MedicineNet Medications General
Title: acyclovir, Zovirax
Category: Medications
Created: 12/31/1997
Last Editorial Review: 8/7/2008
Category: Medications
Created: 12/31/1997
Last Editorial Review: 8/7/2008
MedicineNet Medications General
Title: Birth Control Pills (Oral Contraceptives)
Category: Medications
Created: 12/31/1997
Last Editorial Review: 7/14/2008
Category: Medications
Created: 12/31/1997
Last Editorial Review: 7/14/2008
MedicineNet Medications General
Title: ciprofloxacin, Cipro, Cipro XR, Proquin XR
Category: Medications
Created: 12/31/1997
Last Editorial Review: 7/12/2008
Category: Medications
Created: 12/31/1997
Last Editorial Review: 7/12/2008
MedicineNet Medications General
Title: ofloxacin, Floxin
Category: Medications
Created: 12/31/1997
Last Editorial Review: 7/12/2008
Category: Medications
Created: 12/31/1997
Last Editorial Review: 7/12/2008
MedicineNet Medications General
Title: colesevelam, Welchol
Category: Medications
Created: 8/9/2004 8:41:00 PM
Last Editorial Review: 5/13/2008
Category: Medications
Created: 8/9/2004 8:41:00 PM
Last Editorial Review: 5/13/2008
MedicineNet Medications General
Title: tegaserod, Zelnorm
Category: Medications
Created: 2/27/2003 7:13:00 AM
Last Editorial Review: 4/21/2008
Category: Medications
Created: 2/27/2003 7:13:00 AM
Last Editorial Review: 4/21/2008
MedicineNet Medications General
Title: ezetimibe, Zetia
Category: Medications
Created: 2/5/2003 10:50:00 PM
Last Editorial Review: 4/16/2008
Category: Medications
Created: 2/5/2003 10:50:00 PM
Last Editorial Review: 4/16/2008
MedicineNet Medications General
Title: ezetimibe and simvastatin, Vytorin
Category: Medications
Created: 1/31/2005 10:17:00 PM
Last Editorial Review: 4/16/2008
Category: Medications
Created: 1/31/2005 10:17:00 PM
Last Editorial Review: 4/16/2008
MedicineNet Medications General
Title: isotretinoin, Accutane, Sotret, Claravis, Amnesteem
Category: Medications
Created: 12/31/1997
Last Editorial Review: 4/16/2008
Category: Medications
Created: 12/31/1997
Last Editorial Review: 4/16/2008
MRSA / Drug Resistance News From Medical News Today
Doctors at the University of Virginia Health System have significantly reduced MRSA infections among surgical intensive care patients by using antibiotic cycling, a method of rotating drugs at regular intervals. In a study published in the September 3, 2008 issue of Surgical Infections, UVA researchers report that switching between two antibiotics, linezolid and vancomycin, every three months in the surgical ICU decreased the MRSA infection rate from 1.9 to 1.
MRSA / Drug Resistance News From Medical News Today
Targanta Therapeutics Corporation (Nasdaq: TARG) announced positive top-line results from a Phase 2 clinical trial investigating the efficacy and safety of oritavancin at Single or Infrequent Doses for the Treatment of Complicated Skin and Skin Structure Infections (cSSSI), or SIMPLIFI. Oritavancin is Targanta's lead antibiotic candidate targeting gram-positive organisms, including methicillin-resistant Staphylococcus aureus, or MRSA.
MRSA / Drug Resistance News From Medical News Today
Akorn-Strides, LLC announced the approval of two ANDAs for Dexamethasone Sodium Phosphate Injection USP, 4 mg (base)/mL in 1mL, 5 mL, and 30 mL vials, and Dexamethasone Sodium Phosphate Injection USP, 10 mg (base)/mL in 10 mL vials. Akorn-Strides, LLC is a Joint Venture that was formed in 2005 by Akorn, Inc. (NASDAQ: AKRX) and Strides Arcolab Limited (NSE: STAR)(BSE: 532531).
MRSA / Drug Resistance News From Medical News Today
ZEFTERA has been approved by Health Canada for the treatment of complicated skin and skin structure infections (cSSSI), including non-limb-threatening diabetic foot infections without concomitant osteomyelitis. This approval makes ZEFTERA the only approved antibiotic in its class (cephalosporin) to demonstrate efficacy against Methicillin-resistant Staphylococcus aureus (MRSA), a growing public health concern in both hospital and community settings.
MRSA / Drug Resistance News From Medical News Today
Reacting to news that the number of deaths involving clostridium difficile rose by 28 per cent between 2006 and 2007, Kate Jopling, Head of Public Affairs at Help the Aged, says: "This shocking rise is stacked on top of a huge rise in deaths involving clostridium difficile the previous year - the vast majority of people who die are aged 65 and over(1).
MRSA / Drug Resistance News From Medical News Today
Many nursing mothers who have been hospitalized for breast abscesses are afflicted with the "superbug" methicillin-resistant Staphylococcus aureus, or MRSA, but according to new research by UT Southwestern Medical Center physicians, conservative treatment can deal with the problem.
MRSA / Drug Resistance News From Medical News Today
By manipulating the machinery used by our cells for quality control, researchers from the University of Pittsburgh have found a way to restore the function of cystic fibrosis (CF) airway cells. This could significantly reduce the sticky mucus that plugs the lungs of CF patients, which leads to antibiotic-resistant infections and untimely death. The study, appearing in the September 2008 print issue of The FASEB Journal (
MRSA / Drug Resistance News From Medical News Today
Researchers at the Moores Cancer Center at the University of California, San Diego (UC SD) in La Jolla have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient. They have shown that when a variant version of a key protein that normally causes cell death is active, patients may be resistant to the cancer-killing drug.
MRSA / Drug Resistance News From Medical News Today
Improvements in the prevention of catheter-related infections will be a prime focus at the annual conference of the Association for Vascular Access (AVA) in Sept. The conference comes on the eve of major changes in Medicare that will eliminate payments to hospitals that fail to prevent certain hospital-acquired infections. AVA will hold its 22nd Annual Scientific Meeting Sept. 11-14 in Savannah, Ga.
MRSA / Drug Resistance News From Medical News Today
Australian hospitals should avoid prescribing expensive broad-spectrum antibiotics for pneumonia to avoid the development of more drug-resistant super bugs, according to a University of Melbourne study.
MRSA / Drug Resistance News From Medical News Today
PolyMedix, Inc. (OTC BB: PYMX), an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has initiated dosing and commenced a Phase I clinical study in Canada for its defensin mimetic antibiotic compound, PMX-30063. PolyMedix received a notice of no objection from Health Canada for the Company's Clinical Trial Application ("CTA") for PMX-30063 in May 2008.
MRSA / Drug Resistance News From Medical News Today
Scientists at UT Southwestern Medical Center have found a potential new way to stop the bacteria that cause gastroenteritis, tularemia and severe diarrhea from making people sick. The researchers found that the molecule LED209 interferes with the biochemical signals that cause bacteria in our bodies to release toxins. "What we have here is a completely novel approach to combating illness," said Dr.
MRSA / Drug Resistance News From Medical News Today
Peter Rothschild, M.D., renowned Radiologist and MRI expert, has released the ground-breaking paper, recently published on AuntMinnie.com, titled "Preventing Infection in MRI: Best Practices for Infection Control in and Around MRI Suites." This article expands on the issue that MRIs are often not being properly cleaned, thus leading to concern over Methicillin Resistant Staphylococcus Aureus (MRSA) spread during radiological scans, in particular MRI.
MRSA / Drug Resistance News From Medical News Today
Many drugs once considered Charles Atlases of the pharmaceutical realm have been reduced to the therapeutic equivalent of 97-pound weaklings as the diseases they once dispatched with ease have developed resistance to them. The problem is well documented for antibiotics, although not confined to them. Chemotherapy drugs that were once highly effective when first used against a particular cancer now are often rendered near powerless when a patient's cancer resurges.
MRSA / Drug Resistance News From Medical News Today
SinoFresh HealthCare, Inc. (OTCBB: SFSH) announced preliminary results today from a successful in vivo pilot study indicating that its patented SinoFresh® nasal spray was shown to be useful in controlling the MRSA "super-bug" in the nasal passages. This study utilized a recognized scientific model intended to demonstrate SinoFresh® nasal spray's ability to kill MRSA hiding in the nasal passages.
MRSA / Drug Resistance News From Medical News Today
Hospital-acquired infections until recently were "considered an unavoidable risk," but "now there is proof that nearly all hospital infections are avoidable when doctors and staff clean their hands and rigorously practice proper hygiene and other preventive measures," Betsy McCaughey, chair of the Committee to Reduce Infection Deaths and a former lieutenant governor of New York, writes in a
MRSA / Drug Resistance News From Medical News Today
In the first statewide study of extensively drug-resistant tuberculosis (XDR TB) in the United States, California officials have identified 18 cases of the dangerous and difficult-to-treat disease between 1993 and 2006, and 77 cases that were one step away from XDR TB. The study appears in the August 15 issue of Clinical Infectious Diseases, now available online. California reports almost 3,000 cases of tuberculosis annually, the largest number of TB cases of any U.S. state.
MRSA / Drug Resistance News From Medical News Today
More than 17% of HIV-positive patients in 28 China provinces developed resistance to at least one available HIV/AIDS drug by 2006 and 2007, Chinese government researchers announced at the XVII International AIDS Conference in Mexico City, Reuters reports.
MRSA / Drug Resistance News From Medical News Today
GTCbio just announced its inaugural Bugs & Drugs conference - one of the leading forums to address unmet medical needs for problematic microbials - taking place on September 22-23, 2008 in San Diego, CA. Infections are becoming increasingly problematic due to the recent resistances to current antibiotics. Patients suffering from resistant bugs (hospital-acquired or community-acquired) now need new yet unavailable treatments to combat their infections.
MRSA / Drug Resistance News From Medical News Today
In a retrospective study of 174 tuberculosis patients treated at National Jewish Health (formerly National Jewish Medical and Research Center), patients with extensively-drug-resistant tuberculosis (XDR-TB) were almost eight times as likely to die as patients with multi-drug resistant tuberculosis (MDR-TB).
MRSA / Drug Resistance News From Medical News Today
The death sentence that too often accompanies a diagnosis of extensively drug-resistant tuberculosis (XDR-TB) can be commuted if an individualized outpatient therapy program is followed - even in countries with limited resources and a heavy burden of TB. A study conducted in Peru between 1999 and 2002 shows that more than 60 percent of XDR-TB patients not co-infected with HIV were cured after receiving the bulk of their personalized treatment at home or in community-based settings.
MRSA / Drug Resistance News From Medical News Today
Scientists at Swansea University have discovered a new type of antibiotic in maggot secretions that can tackle up to 12 different strains of MRSA, as well as E. coli and C. difficile. This research was funded by leading charity Action Medical Research, with support from the Rosetrees Trust.
MRSA / Drug Resistance News From Medical News Today
Diatherix Laboratories, an independent clinical reference laboratory located in the Hudson-Alpha Institute for Biotechnology, announced it has received its Clinical Laboratory Improvement Amendment (CLIA) certificate* for its proprietary licensed testing process, Target Enriched Multiplex Polymerase Chain Reaction (Tem-PCR).
MRSA / Drug Resistance News From Medical News Today
Infections following treatment in clinics, retirement homes, and long-term care facilities are a grave problem for patients, and resistant germs can be particularly devastating.
MRSA / Drug Resistance News From Medical News Today
One of the major reasons that treatment for HIV/AIDS often doesn't work as well as it should is resistance to the drugs involved. Now, scientists at McGill University have revealed how mutations hidden in previously ignored parts of the HIV genome play an important role in the development of drug resistance in AIDS patients. Their study will be published Aug. 8 in the Journal of Biological Chemistry.
| ||||||||||||||||||
| ||||||||||||||||||